Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Oral Oncol. 2016 Nov 23;63:66–73. doi: 10.1016/j.oraloncology.2016.11.005

Table 3.

Patient Characteristics

Characteristic N (%)
Patient Age at Diagnosis <40 29 (6%)
40-49 68 (13%)
50-59 138 (27%)
60-69 118 (23%)
70-79 93 (18%)
80+ 59 (12%)
Race White 471 (93%)
Black 13 (3%)
Other/unknown 21 (4%)
Sex Male 288 (57%)
Female 217 (43%)
Smoking Status, n=492 Current Smoker (past 12 months) 215 (44%)
Former Smoker (quit > 12 months) 152 (31%)
Never Smoker 125 (25%)
ACE-27 Comorbidity Score, n=502 none 112 (22%)
mild 227 (45%)
moderate 111(22%)
severe 52 (10%)
Prior Cancer, n=502 Yes 72 (14%)
No 430 (86%)
Cancer Site and Stage Oral Cavity site Tongue 227 (45%)
Floor of Mouth 95 (19%)
Gum/other 180 (36%)
Lip 3 (<1%)
Grade, n=481 I: Well 141 (29%)
II: Moderate 293 (61%)
III: Poor 47 (10%)
T class T1 129 (26%)
T2 136 (27%)
T3 50 (10%)
T4a 187 (37%)
T4b 3 (<1%)
N class N0 315 (62%)
N1 69 (14%)
N2a 11 (2%)
N2b 72 (14%)
N2c 35 (7%)
N3 3 (<1%)
Tumor Size (greatest dimension), n=495 <1.5 cm 14 (3%)
1.5 cm-2.9 cm 171 (35%)
3 cm -5.9 cm 241 (49%)
6 cm+ 69 (14%)
Number of Nodes, n=460 0 315 (68%)
1 77 (17%)
2 21 (5%)
3 18 (4%)
4 10 (2%)
5+ 19 (4%)
High Risk Features ECS ESC Present 62 (12%)
Muscle Invasion Present 50 (10%)